At the end of August, I reported that "The Pure-Play Pot Stock Portfolio was UP 8.3% in August" but so far this September the portfolio is DOWN 11.1% with only 1 of the 25 stocks in the portfolio - just one - advancing. 

The Only Winner

The only participant to advance so far in September is Jushi (JUSHF) which is UP 9.7% strengthening its performance as one of only 9 stocks in the portfolio that is UP this year (+71.7%). See Q2 Financials here.

Major Losers

The remaining 24 participants are DOWN in price so far this September with 15 declining by 9.7% or more, namely:

1. Aurora (ACB) -27.9%
2. Greenlane (GNLN) -24.8% (see Q2 Financials)
3. Tilray (TLRY) -21.2%
4. Cresco (CRLBF) -19.1% (see Q2 Financials)
5. Curaleaf (CURLF) -17.4% (see Q2 Financials)
6. Charlotte's Web (CWBHF) -16.5% (see Q2 Financials)
7. Organigram (OGI) -15.1%
8. Valens (VLNCF) -14.2%
9. Neptune (NEPT) -12.4%
10. Green Thumb (GTBIF) -12.0% (see Q2 Financials)
11. Avicanna (AVCNF) -12.0%
12. cbdMD (YCBD) -11.7%
13. Trulieve (TCNNF) -10.5% (see Q2 Financials)
14. Columbia (CCHWF) -9.8% (see Q2 Financials)
15. Planet 13 (PLNHF) -9.7% (see Q2 Financials)

The 25 munKNEE Pure-Play Pot Stock Portfolio includes companies doing business in 4 categories based on their primary area of focus in the cannabis industry. The categories are identified below with how they performed given the performance of the stocks in the portfolio that make up each category:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and it is DOWN 10.7%.
   • the 7 Canadian Licensed Producer (LPs) portfolio participants  (ACB; CGC; CRON; OGI; ROMJF and TLRY) are DOWN 10.7%, on average.
   • the 12 U.S. Multi-State Operator (MSOs) portfolio participants (ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; HRVSF; JUSHF;   PLNHF; SHWZ; TCNNF and TRSSF) are DOWN 10.5%, on average.
   • the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and  YCBD) are DOWN 14.5%, on average.
2. The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they are DOWN 13.1%, on average.
3. The Consumption Devices Category has only 1 portfolio participant  (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it is DOWN 24.8% in price.
4. The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it is DOWN 12.0%.

*Please note: The 25 pure-play stocks in the munKNEE Pure-Play Pot Stock Portfolio are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products and, as such, it reflects the true health of the marijuana industry in the U.S. and Canada.